Optimal de novo Design of MRM Experiments for Rapid Assay Development in Targeted Proteomics

被引:31
|
作者
Bertsch, Andreas [1 ]
Jung, Stephan [2 ]
Zerck, Alexandra [3 ]
Pfeifer, Nice [1 ]
Nahnsen, Sven [1 ,2 ]
Henneges, Carsten [1 ]
Nordheim, Alfred [2 ,4 ]
Kohlbacher, Oliver [1 ]
机构
[1] Univ Tubingen, Ctr Bioinformat, D-72074 Tubingen, Germany
[2] Univ Tubingen, Proteome Ctr Tubingen, D-72074 Tubingen, Germany
[3] Max Planck Inst Mol Genet, Berlin, Germany
[4] Univ Tubingen, Interfac Inst Cell Biol, D-72074 Tubingen, Germany
关键词
SRM; MRM; ILP; OpenMS; prediction; MASS-SPECTROMETRY; PEPTIDES; PREDICTION; PROTEINS; HYPOTHESIS; SPECTRA; YEAST;
D O I
10.1021/pr1001803
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Targeted proteomic approaches such as multiple reaction monitoring (MRM) overcome problems associated with classical shotgun mass spectrometry experiments. Developing MRM quantitation assays can be time consuming, because relevant peptide representatives of the proteins must be found and their retention time and the product ions must be determined. Given the transitions, hundreds to thousands of them can be scheduled into one experiment run. However, it is difficult to select which of the transitions should be included into a measurement. We present a novel algorithm that allows the construction of MRM assays from the sequence of the targeted proteins alone. This enables the rapid development of targeted MRM experiments without large libraries of transitions or peptide spectra. The approach relies on combinatorial optimization in combination with machine learning techniques to predict proteotypicity, retention time, and fragmentation of peptides. The resulting potential transitions are scheduled optimally by solving an integer linear program. We demonstrate that fully automated construction of MRM experiments from protein sequences alone is possible and over 80% coverage of the targeted proteins can be achieved without further optimization of the assay.
引用
收藏
页码:2696 / 2704
页数:9
相关论文
共 50 条
  • [21] Development of the de novo pyrosequencing assay system for HCV genotyping and mutation analysis
    Yeh, Y-M
    Ko, H-Y
    Hsu, L-K
    Tien, H-L
    Liu, Y-Z
    Liu, M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 86 - 86
  • [22] Dataset describing the development, optimization and application of SRM/MRM based targeted proteomics strategy for quantification of potential biomarkers of EGFR TKI sensitivity
    Awasthi, Shivangi
    Maity, Tapan
    Oyler, Benjamin L.
    Zhang, Xu
    Goodlett, David R.
    Guha, Udayan
    [J]. DATA IN BRIEF, 2018, 19 : 424 - 436
  • [23] Fuzzy Static and Dynamic De Novo Type Approaches to Optimal System Design
    Kacprzyk, Janusz
    [J]. INTELLIGENT AND FUZZY SYSTEMS: DIGITAL ACCELERATION AND THE NEW NORMAL, INFUS 2022, VOL 1, 2022, 504 : 3 - 6
  • [24] In silico de novo development and design of ligands for organometallic biomimetic catalysts
    Nguyen, Linh T.
    DeYonker, Nathan J.
    Webster, Charles E.
    Zhao, Xuan
    Shelton, G. Robert
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [25] Development of a New De Novo Design Algorithm for Exploring Chemical Space
    Mishima, Kazuaki
    Kaneko, Hiromasa
    Funatsu, Kimito
    [J]. MOLECULAR INFORMATICS, 2014, 33 (11-12) : 779 - 789
  • [26] Optimal design of dynamic experiments in the development of cybernetic models for bioreactors
    Luna, Martin F.
    Martinez, Ernesto C.
    [J]. CHEMICAL ENGINEERING RESEARCH & DESIGN, 2018, 136 : 334 - 346
  • [27] De novo design of importin-α-specific NLS sequences for nuclear-targeted therapeutics
    Bednova, Olga
    Rioux-Chevalier, Alexis
    Patel, Dipika
    Boudreau, Mathieu
    Leyton, Jeffrey Victor
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [28] Event-triggered optimal interaction control of the MRM system under the complex multi-task constraints: Design and experiments
    Li, Yuanchun
    Yao, Ximing
    Ma, Bing
    [J]. Journal of the Franklin Institute, 2023, 360 (02) : 910 - 942
  • [29] De Novo Development of a Universal Biosensing Platform by Rapid Direct Native Protein Modification
    Hua, Xinyi
    Wang, Zhifang
    Wang, Ziqi
    Chen, Linlin
    Zhou, Zaichun
    Ouyang, Junlin
    Deng, Keqin
    Yang, Xiumei
    Huang, Haowen
    [J]. ANALYTICAL CHEMISTRY, 2021, 93 (12) : 5291 - 5300
  • [30] De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
    Ben-Uliel, Shulamit Fluss
    Zoabi, Faten Habrat
    Slavin, Moriya
    Sibony-Benyamini, Hadas
    Kalisman, Nir
    Qvit, Nir
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)